Genital Diseases, Female  >>  zibotentan (ZD4054)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
zibotentan (ZD4054) / AstraZeneca
NCT00929162 / 2008-006068-12: ZD4054 (Zibotentan) or Placebo Plus Chemotherapy in Patients With Advanced Ovarian Cancer

Terminated
2
120
Europe
ZD4054 Zibotentan, Paclitaxel, Carboplatin, Placebo
AstraZeneca, ISTITUTO REGINA ELENA - CENTRO RICERCHE SPERIMENTALI
Patients With Advanced Ovarian Cancer Sensitive to Platinum-based Chemotherapy
06/11
06/11

Download Options